| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2489747-26-2 | Mirabegron Impurity 2 | C26H28N6O3S2 |
| 2492423-29-5 | EIDD-2801 | C13H19N3O7 |
| 2496497-75-5 | (1R,4R)-4-Amino-2,2-difluorocyclopentane-1-carboxylic acid hydrochloride | C6H10ClF2NO2 |
| 2496497-79-9 | (1S,4S)-4-Amino-2,2-difluorocyclopentane-1-carboxylic acid hydrochloride | C6H10ClF2NO2 |
| 2497340-56-2 | Baricitinib Impurity 4 Hydrochloride | C14H14ClN7 |
| 2499663-01-1 | Stm2457 | C25H28N6O2 |
| 2500321-37-7 | Eltrombopag Impurity 16 | C14H18N2O |
| 2503325-78-6 | (R)-4,4-Difluoro-3-methylpiperidine hydrochloride | C6H12ClF2N |
| 2504915-16-4 | Tert-butyl 4-(3-formyl-4-(methoxycarbonyl)phenyl)piperazine-1-carboxylate | C18H24N2O5 |
| 2511244-97-4 | Ivabradine N-Oxide Impurity | C27H36N2O6 |
| 2511500-14-2 | Bempedoic Acid Impurity 24 | C21H40O5 |
| 2512190-67-7 | Vigabatrin Impurity 2 | C12H17NO4 |
| 2512197-16-7 | 1,1'-Bis(2,6-dichlorophenyl)-[5,5'-biindoline]-2,2'-dione | C28H16Cl4N2O2 |
| 2512200-37-0 | Vilazodone Impurity 10 | C13H11ClN2O |
| 2512206-40-3 | Sildenafil Methyl Sulfonate Ester Impurity | C18H22N4O5S |
| 2512216-37-2 | Esomeprazole Impurity 2 | C16H17N3O2 |
| 2514236-16-7 | Cinacalcet Impurity 2 HCl | C12H15N .HCl |
| 2514625-50-2 | Cinacalcet Impurity 8 HCl | C12H15N .HCl |
| 2514682-10-9 | Mesalazine (Mesalamine) EP Impurity J DiHCl | C7H8N2O3 .2HCl |
| 2514947-17-0 | Formoterol Impurity H | C26H30N2O4 |
| 2514949-81-4 | Linagliptin Impurity 20 | C20H28N4O2 |
| 2514957-39-0 | Regorafenib FP Impurity A | C16H16FN3O4 |
| 2514961-29-4 | N-(4-(4-Acetamido-2-hydroxyphenoxy)phenyl)acetamide | C16H16N2O4 |
| 2517638-29-6 | 4-(Azidomethyl)-L-phenylalanine hydrochloride | C10H13ClN4O2 |
| 2517869-09-7 | Omeprazole Impurity 29 HCl | C11H15NO3 .HCl |
| 2517964-85-9 | Abiraterone Acetate N-Oxide | C26H33NO3 |
| 2517968-40-8 | Bendamustine Deschloroethyl Acid Ethyl Ester | C16H22ClN3O2 |
| 2518010-91-6 | Cinacalcet Impurity 22 | C20H18F3N |
| 2518198-73-5 | Sibutramine Impurity 1 | C13H18ClN |
| 2519517-77-0 | Olopatadine Carbaldehyde Impurity | C20H21NO2 .HCl |
| 2520114-41-2 | Tadalafil EP Impurity E | C22H19N3O6 |
| 2520114-46-7 | Tadalafil - Impurity G | C22H17N3O5 |
| 2545933-24-0 | Regorafenib Impurity 16 | C25H22FN5O4 |
| 2553413-93-5 | Dazostinag disodium | C21H20F2N8Na2O10P2S2 |
| 2565657-41-0 | tert-Butyl (R)-3-((S)-1-((S)-4-benzyl-2-oxooxazolidin-3-yl)-3-(3-bromophenyl)-1-oxopropan-2-yl)pyrrolidine-1-carboxylate | C28H33BrN2O5 |
| 2565657-65-8 | tert-Butyl (R)-3-((S)-3-(3-bromophenyl)-1-(tert-butoxy)-1-oxopropan-2-yl)pyrrolidine-1-carboxylate | C22H32BrNO4 |
| 2565657-83-0 | tert-Butyl (R)-3-((S)-1-(tert-butoxy)-3-(3-hydroxyphenyl)-1-oxopropan-2-yl)pyrrolidine-1-carboxylate | C22H33NO5 |
| 2565657-87-4 | tert-butyl (S)-3-((S)-1-(tert-butoxy)-3-(3-(((3-((S)-3-(tert-butoxy)-2-((R)-1-(tert-butoxycarbonyl)pyrrolidin-3-yl)-3-oxopropyl)benzyl)amino)methyl)phenyl)-1-oxopropan-2-yl)pyrrolidine-1-carboxylate | C46H69N3O8 |
| 2565705-03-3 | Dot1L-IN-5 | C23H19ClF2N8O5S |
| 2567457-10-5 | (6-Amino-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)dimethylphosphine oxide | C10H14NO3P |
| 2568974-02-5 | Edoxaban Dipyridine Impurity | C23H25Cl2N7O5 |
| 2569798-24-7 | 2-(6-Chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine | C27H18ClN3 |
| 2575516-61-7 | Paracetamol EP Impurity O | C16H16N2O4 |
| 2582757-90-0 | Stafia-1 | C24H27O10P |
| 2586127-25-3 | 4,5-Dichloro-3-iodo-1H-indazole | C7H3Cl2IN2 |
| 2587607-84-7 | Eltrombopag Olamine impurity 08 | C27H27N5O4 |
| 2589531-78-0 | 7-(Chloromethyl)-3-ethyl-1H-1,5-naphthyridin-2-one | C11H11ClN2O |
| 2595050-21-6 | Tetradecanoic acid 9H-fluoren-9-yl ester | C27H36O2 |
| 2597333-33-8 | (cis)-benzyl 3a-fluorohexahydropyrrolo[3,4-b]pyrrole-1(2H)-carboxylate hydrochloride | |
| 2597334-97-7 | (cis)-Benzyl 3,3-difluorohexahydropyrrolo[3,4-b]pyrrole-1(2H)-carboxylate hydrochloride |